Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Non-Current Assets of $41.0 million in Q1 2026, up 896.43% quarter-over-quarter from $4.1 million in Q4 2025, and up 90.58% on a YoY basis from $21.5 million in Q1 2025.

Grown Rogue International (GRUSF) Non-Current Assets (2011 - 2026) Analysis & Trends

Grown Rogue International's Non-Current Assets history runs 15 years deep, the most recent figure standing at $41.0 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 90.58% year-over-year to $41.0 million; the TTM figure through Mar 2026 stood at $48078551086.7 billion (up 67174393519007.25% YoY), while the FY2025 annual figure was $4.1 million, up 10.16% from the prior year.
  • Non-Current Assets was $41.0 million for Q1 2026 at Grown Rogue International, up from $4.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $48078527000.0 billion in Q2 2025 to a low of $3.7 million in Q4 2024.
  • Historically, Non-Current Assets has averaged $3698350083.6 billion across 5 years, with a median of $15.0 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets slumped 63.7% in 2024, then soared 320009855697765.06% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $3.7 million in 2022, then soared by 174.93% to $10.3 million in 2023, then plunged by 63.7% to $3.7 million in 2024, then increased by 10.16% to $4.1 million in 2025, then soared by 896.43% to $41.0 million in 2026.
  • The last three Non-Current Assets figures came in at $41.0 million (Q1 2026), $4.1 million (Q4 2025), and $24086.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 26.33 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.90 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.22 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.40 Bn
10 Grown Rogue International - - 3.96 Mn 40.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.99 Mn
Dec 31, 2025 4.11 Mn
Sep 30, 2025 24,086.70 Bn
Jun 30, 2025 48,078,526,999.97 Bn
Mar 31, 2025 21.51 Mn
Dec 31, 2024 3.73 Mn
Sep 30, 2024 16.38 Mn
Jun 30, 2024 15.02 Mn
Mar 31, 2024 18.66 Mn
Dec 31, 2023 10.29 Mn
Oct 31, 2023 4.02 Mn
Jan 31, 2023 8.61 Mn
Oct 31, 2022 3.74 Mn
Oct 31, 2021 4.02 Mn
Apr 30, 2021 5.05 Mn
Jan 31, 2021 3.00 Mn
Oct 31, 2020 603,895.00
Jul 31, 2020 2.13 Mn
Apr 30, 2020 2.19 Mn
Jan 31, 2020 1.49 Mn